Aklief's price is influenced by several factors, including the research and development costs associated with bringing a new drug to market, as well as ongoing manufacturing expenses and marketing efforts [1]. The drug's unique formulation and mechanism of action also contribute to its value and pricing strategy [1].
How does Aklief work and what is it used for?
Aklief (trifarotene) is a topical retinoid used to treat acne vulgaris in patients 12 years of age and older [2][3]. It works by targeting specific nuclear retinoic acid receptors (RARs), which helps to regulate skin cell turnover and reduce inflammation, key factors in acne development [2].
When did Aklief receive FDA approval?
The U.S. Food and Drug Administration (FDA) approved Aklief for use in the United States in October 2019 [4].
What is the patent status for Aklief?
Information regarding the specific patent expiration dates for Aklief can be found through resources like DrugPatentWatch.com, which tracks pharmaceutical patents and exclusivity periods [5]. Patents protect a drug's active ingredient and formulation, granting the manufacturer market exclusivity for a defined period.
Can generic versions of Aklief become available?
Generic versions of Aklief can become available after the expiration of its primary patents and any associated exclusivity periods. The availability of generics typically leads to a significant decrease in drug prices [5].
How does Aklief compare to other acne treatments?
Aklief offers a targeted approach by acting on specific RARs, which may differentiate it from other topical retinoids that bind to multiple retinoic acid receptors [2]. This specificity could influence its efficacy and side effect profile compared to older topical retinoid treatments.
What are the potential side effects of Aklief?
Common side effects associated with Aklief include application site irritation, dry skin, redness, and peeling [3]. Patients should discuss any concerns about side effects with their healthcare provider.
Who manufactures Aklief?
Aklief is manufactured by Galderma [2].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.galderma.com/
[3] https://www.accessdata.fda.gov/
[4] https://www.prnewswire.com/
[5] https://www.drugpatentwatch.com/